Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Moxiwel K
Moxiwel K is an advanced eye drop formulation containing a combination of Moxifloxacin 0.5% and Ketorolac 0.5%, specifically designed to treat ocular infections and manage post-operative inflammation. The dual-action formula effectively addresses both the infection and inflammation that often accompany conditions like conjunctivitis, keratitis, and after eye surgeries. This combination offers targeted treatment, ensuring a fast and effective solution for eye-related issues while minimizing the need for multiple medications.
Uses of Moxiwel K
Moxiwel K is indicated for:
Bacterial Conjunctivitis (Pink Eye)
Keratitis (Corneal Infections)
Post-Surgical Inflammation and Pain Relief
Inflammatory Conditions of the Eye due to Infection
Benefits of Moxiwel K
Dual Action against Infections and Inflammation
Moxifloxacin provides broad-spectrum antimicrobial activity
Ketorolac offers anti-inflammatory and analgesic properties
Relieves Redness, Swelling, and Pain
Effective Treatment for Both Infected and Inflamed Eyes
Fast-Acting with Minimal Side Effects
Mechanism of Action of Moxiwel K
Moxifloxacin: An antibiotic that inhibits bacterial DNA gyrase, blocking the replication of bacteria and clearing infections.
Ketorolac: A NSAID that works by inhibiting the enzyme cyclooxygenase (COX), reducing the production of prostaglandins, which cause inflammation, pain, and fever.